Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 81, 2021 - Issue 7
Submit an article Journal homepage
143
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of the interference of lamotrigine on the analysis of synthetic cannabinoids in urine by the immunoassay method

Hüseyin Kurkua Department of Biochemistry, Konya Beyhekim Training and Research Hospital, Konya, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1083-4151
ORCID Icon,
Bilge Çetin İlhanb Clinic of Psychiatry, Konya Beyhekim Training and Research Hospital, Konya, Turkey
,
Ömer Kayac Department of Biochemistry, Konya Training and Research Hospital, Konya, Turkey
&
Semra Aydın Akfıratd Department of Biochemistry, ToksiLab Toxicology Laboratory, İstanbul, Turkey
Pages 532-539 | Received 22 Apr 2021, Accepted 26 Jul 2021, Published online: 11 Aug 2021

References

  • Küme T, Karakükcü Ç, Pinar A, et al. The scope, quality and safety requirements of drug abuse testing/yasadisi ve kötüye kullanilan madde analizlerinin kapsami, kalite ve güvenlik gereklilikleri. Turk Psikiyatri Dergisi. 2017;28(3):198–207.
  • Akyüzlü DK, Kayaaltı ZZ. Blood, hair, urine and breath samples for the analysis of drugs of abuse. Marmara Pharm J. 2015;19(3):232–237.
  • Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157–162.
  • Moeller KE, Kissack JC, Atayee RS, et al. Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens. Mayo Clin Proc. 2017;92(5):774–796.
  • Christensen J, Petrenaite V, Atterman J, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia. 2007;48(3):484–489.
  • Garnett WR. Lamotrigine: pharmacokinetics. J Child Neurol. 1997;12(1):S10–S15.
  • LUCIO®-Drug EIA SPICE JWH-018 [package insert]. Version 1.1, 2017-10-18 ed: nal von minden GmbH, Moers, Germany; 2017.
  • McEnroe RJ, Burritt MF, Powers DM, et al. Interference testing in clinical chemistry; approved guideline. 2nd ed. Wayne (PA): Clinical Laboratory Standards Institute; 2005. CLSI document EP7–A2.
  • pinral® 25 mg çözünür/çiğneme tablet; chewable/soluble tablet (Lamotrigine 25 mg), [package insert]. İstanbul, Türkiye: Sanovel İlaç; 2014.
  • Jang M, Yang W, Choi H, et al. Monitoring of urinary metabolites of JWH-018 and JWH-073 in legal cases. Forensic Sci Int. 2013;231(1–3):13–19.
  • LAMICTAL® DC 100 mg çözünür/çiğneme tablet; chewable/soluble tablet (lamotrigine 100mg), [package insert] GlaxoSmithKline İlaçları San. ve Tic. A.Ş. İstanbul, Türkiye; 2017.
  • Karakukcu C, Ciraci MZ, Kocer D, et al. Regional drug abuse prevalence depending on laboratory based urine illicit drug screening results/laboratuvar verilerine dayali idrarda yasa disi madde analiz sonuclarina gore bolgesel madde kullanim yayginliginin belirlenmesi. Anadolu Psikiyatri Dergisi. 2018;19(2):169–177.
  • Kurku H. Administrative regulations for illegal and drug abuse testing analysis laboratories/yasadışı ve kötüye kullanılan madde analiz laboratuvarları için idari düzenlemeler. In: Yücel D, editor. Güncel biyokimya çalışmaları I. Vol. 1. Ankara, Turkey: Akademisyen Kitabevi; 2019. p. 1–16.
  • Barnes AJ, Young S, Spinelli E, et al. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine. Forensic Sci Int. 2014;241:27–34.
  • Barnes AJ, Spinelli E, Young S, et al. Validation of an ELISA synthetic cannabinoids urine assay. Ther Drug Monit. 2015;37(5):661–669.
  • DrugCheck® K2/spice test [package insert]. Blue Earth (MN): Express Diagnostic Int’l Inc; 2012.
  • Küme T, Karakükcü Ç, Uzun NK, et al. Drug abuse testing in clinical laboratories/tıbbi laboratuvarlarda madde analizleri. Türk Klinik Biyokimya Derg. 2016;14(1):58–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.